FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Donald Trump

Research Profile

Chemicals & Drugs

Disorders

Living Beings

Procedures

Antineoplastic Combined Chemotherapy Protocols

Concepts & Ideas

Anatomy

Physiology

Co-author Network

Publications

TOP 3
Yingyu Ma; Wei-Dong Yu; REMI DELANSORNE; Alejandro A Hidalgo; Candace S Johnson; Wei Luo; Donald L Trump
Inecalcitol, an analog of 1,25D3, displays enhanced antitumor activity through the induction of apoptosis in a squamous cell carcinoma model system.
Yingyu Ma; Mukund Seshadri; Bing Su; Donald L Trump; Wei-Dong Yu; Wei Luo; Candace S Johnson
Regulation of motility, invasion, and metastatic potential of squamous cell carcinoma by 1α,25-dihydroxycholecalciferol.
Song Yao; Hua Zhao; Gary Zirpoli; Foluso Ademuyiwa; Elisa Bandera; Dana H Bovbjerg; Gregory Ciupak; Warren Davis; Chi Chen Hong; Helena Hwang; Lina Jandorf; Candace S Johnson; Susan E McCann; Karen S Pawlish; Michelle Roberts; Lara E Sucheston; Li Tang; Donald L Trump; Christine B Ambrosone
Variants in the vitamin D pathway, serum levels of vitamin D, and estrogen receptor negative breast cancer among African-American women: a case-control study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Donald Trump (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Yingyu Ma; Wei-Dong Yu; REMI DELANSORNE; Alejandro A Hidalgo; Candace S Johnson; Wei Luo; Donald L Trump
Inecalcitol, an analog of 1,25D3, displays enhanced antitumor activity through the induction of apoptosis in a squamous cell carcinoma model system.
Cell cycle (Georgetown, Tex.) 2013;12(5):743-52.
2013: Yingyu Ma; Mukund Seshadri; Bing Su; Donald L Trump; Wei-Dong Yu; Wei Luo; Candace S Johnson
Regulation of motility, invasion, and metastatic potential of squamous cell carcinoma by 1α,25-dihydroxycholecalciferol.
Cancer 2013;119(3):563-74.
2012: Song Yao; Hua Zhao; Gary Zirpoli; Foluso Ademuyiwa; Elisa Bandera; Dana H Bovbjerg; Gregory Ciupak; Warren Davis; Chi Chen Hong; Helena Hwang; Lina Jandorf; Candace S Johnson; Susan E McCann; Karen S Pawlish; Michelle Roberts; Lara E Sucheston; Li Tang; Donald L Trump; Christine B Ambrosone
Variants in the vitamin D pathway, serum levels of vitamin D, and estrogen receptor negative breast cancer among African-American women: a case-control study.
Breast cancer research : BCR 2012;14(2):R58.
2011: Joseph J Wakshlag; Donald L Trump; Priyanka Vachhani; Erin K Malone; Kenneth M Rassnick; Angela M Struble; Lili Tian
Cross-sectional study to investigate the association between vitamin D status and cutaneous mast cell tumours in Labrador retrievers.
The British journal of nutrition 2011;106 Suppl 1():S60-3.
2011: Anna Woloszynska-Read; Candace S Johnson; Donald L Trump
Vitamin D and cancer: clinical aspects.
Best practice & research. Clinical endocrinology & metabolism 2011;25(4):605-15.
2011: Kristin K Deeb; Candace S Johnson; Adam R Karpf; Wei Luo; Carl D Morrison; Angela R Omilian; Michael A Tangrea; Lili Tian; Wiam Bshara; Donald L Trump
Differential vitamin D 24-hydroxylase/CYP24A1 gene promoter methylation in endothelium from benign and malignant human prostate.
Epigenetics : official journal of the DNA Methylation Society 2011;6(8):994-1000.
2011: Kenneth M Rassnick; Josephia R Muindi; Candace S Johnson; Dennis B Bailey; Donald L Trump
Oral bioavailability of DN101, a concentrated formulation of calcitriol, in tumor-bearing dogs.
Cancer chemotherapy and pharmacology 2011;67(1):165-71.
2011: Ajithkumar Puthillath; Donald L Trump; Chris Andrews; Arvinder Bir; Karen Romano; Michelle Wisniewski; Marwan G Fakih
Serological immune responses to influenza vaccine in patients with colorectal cancer.
Cancer chemotherapy and pharmacology 2011;67(1):111-5.
2010: Josephia R Muindi; Wei-Dong Yu; Yingyu Ma; Kristie L Engler; Rui-Xian Kong; Donald L Trump; Candace S Johnson
CYP24A1 inhibition enhances the antitumor activity of calcitriol.
Endocrinology 2010;151(9):4301-12.
2010: Wei-Dong Yu; Yingyu Ma; Geraldine Flynn; Josephia R Muindi; Rui-Xian Kong; Donald L Trump; Candace S Johnson
Calcitriol enhances gemcitabine anti-tumor activity in vitro and in vivo by promoting apoptosis in a human pancreatic carcinoma model system.
Cell cycle (Georgetown, Tex.) 2010;9(15):3022-9.
2010: Yingyu Ma; Wei-Dong Yu; Donald L Trump; Candace S Johnson
1,25D3 enhances antitumor activity of gemcitabine and cisplatin in human bladder cancer models.
Cancer 2010;116(13):3294-303.
2010: Candace S Johnson; Ivy Chung; Donald L Trump
Epigenetic silencing of CYP24 in the tumor microenvironment.
The Journal of steroid biochemistry and molecular biology 2010;121(1-2):338-42.
2010: Manpreet K Chadha; Lili Tian; Terry Mashtare; Valencia Payne; Carrie Silliman; Ellis Levine; Michael Wong; Candace Johnson; Donald L Trump
Phase 2 trial of weekly intravenous 1,25 dihydroxy cholecalciferol (calcitriol) in combination with dexamethasone for castration-resistant prostate cancer.
Cancer 2010;116(9):2132-9.
2010: Yingyu Ma; Donald L Trump; Candace S Johnson
Vitamin D in combination cancer treatment.
Journal of Cancer 2010;1():101-7.
2010: Donald L Trump; Kristin K Deeb; Candace S Johnson
Vitamin D: considerations in the continued development as an agent for cancer prevention and therapy.
Cancer journal (Sudbury, Mass.) 2010;16(1):1-9.
2009: Josephia R Muindi; Candace S Johnson; Donald L Trump; Renee Christy; Kristie L Engler; Marwan G Fakih
A phase I and pharmacokinetics study of intravenous calcitriol in combination with oral dexamethasone and gefitinib in patients with advanced solid tumors.
Cancer chemotherapy and pharmacology 2009;65(1):33-40.
2009: Donald L Trump; Manpreet K Chadha; Annette Y. Sunga; Marwan G Fakih; Umeer Ashraf; Carrie G Silliman; Bruce W Hollis; Mary K Nesline; Lili Tian; Wei Tan; Candace S Johnson
Vitamin D deficiency and insufficiency among patients with prostate cancer.
BJU international 2009;104(7):909-14.
2009: Ivy Chung; Guangzhou Han; Mukund Seshadri; Bryan M Gillard; Wei-Dong Yu; Barbara A Foster; Donald L Trump; Candace S Johnson
Role of vitamin D receptor in the antiproliferative effects of calcitriol in tumor-derived endothelial cells and tumor angiogenesis in vivo.
Cancer research 2009;69(3):967-75.
2009: Marwan G Fakih; Donald L Trump; Candace S Johnson; Lili Tian; Josephia Muindi; Annette Y. Sunga
Chemotherapy is linked to severe vitamin D deficiency in patients with colorectal cancer.
International journal of colorectal disease 2009;24(2):219-24.
2008: Kenneth M Rassnick; Josephia R Muindi; Candace S Johnson; Cheryl E Balkman; Nithya Ramnath; Wei-Dong Yu; Kristie L Engler; Rodney L Page; Donald L Trump
In vitro and in vivo evaluation of combined calcitriol and cisplatin in dogs with spontaneously occurring tumors.
Cancer chemotherapy and pharmacology 2008;62(5):881-91.
2008: Susan L Greenspan; Joel B Nelson; Donald L Trump; Julie M Wagner; Megan E Miller; Subashan Perera; Neil M Resnick
Skeletal health after continuation, withdrawal, or delay of alendronate in men with prostate cancer undergoing androgen-deprivation therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(27):4426-34.
2008: Manpreet K Chadha; Umeer Ashraf; David Lawrence; Lili Tian; Ellis Levine; Carrie Silliman; Paul Escott; Valencia Payne; Donald L Trump
Phase II study of fulvestrant (Faslodex) in castration resistant prostate cancer.
The Prostate 2008;68(13):1461-6.
2008: Yingyu Ma; Wei-Dong Yu; Pamela A Hershberger; Geraldine Flynn; Rui-Xian Kong; Donald L Trump; Candace S Johnson
1alpha,25-Dihydroxyvitamin D3 potentiates cisplatin antitumor activity by p73 induction in a squamous cell carcinoma model.
Molecular cancer therapeutics 2008;7(9):3047-55.
2008: Yiu-Keung Lau; Manpreet K Chadha; Alan Litwin; Donald L Trump
A dramatic, objective antiandrogen withdrawal response: case report and review of the literature.
Journal of hematology & oncology 2008;1():21.
2007: Ivy Chung; Adam R Karpf; Josephia R Muindi; Jeffrey M Conroy; Norma J Nowak; Candace S Johnson; Donald L Trump
Epigenetic silencing of CYP24 in tumor-derived endothelial cells contributes to selective growth inhibition by calcitriol.
The Journal of biological chemistry 2007;282(12):8704-14.
2007: Susan L Greenspan; Joel B Nelson; Donald L Trump; Neil M Resnick
Effect of once-weekly oral alendronate on bone loss in men receiving androgen deprivation therapy for prostate cancer: a randomized trial.
Annals of internal medicine 2007;146(6):416-24.
2007: Ivy Chung; Wei-Dong Yu; Adam R Karpf; Geraldine Flynn; Ronald J Bernardi; Ruth A Modzelewski; Candace S Johnson; Donald L Trump
Anti-proliferative effects of calcitriol on endothelial cells derived from two different microenvironments.
The Journal of steroid biochemistry and molecular biology 2007;103(3-5):768-70.
2007: Alejandro Hidalgo; Roberto Paredes; Victor M Garcia; Geraldine Flynn; Candace S Johnson; Donald L Trump; Sergio A Onate
Altered VDR-mediated transcriptional activity in prostate cancer stroma.
The Journal of steroid biochemistry and molecular biology 2007;103(3-5):731-6.
2007: Josephia R Muindi; Alain Nganga; Kristie L Engler; Lionel J Coignet; Candace S Johnson; Donald L Trump
CYP24 splicing variants are associated with different patterns of constitutive and calcitriol-inducible CYP24 activity in human prostate cancer cell lines.
The Journal of steroid biochemistry and molecular biology 2007;103(3-5):334-7.
2007: Adebusola A Alagbala; Michael T Moser; Candace S Johnson; Donald L Trump; Barbara A Foster
Characterization of Vitamin D insensitive prostate cancer cells.
The Journal of steroid biochemistry and molecular biology 2007;103(3-5):712-6.
2007: Marwan G Fakih; Donald L Trump; Josephia R Muindi; Jennifer D Black; Ronald J Bernardi; Patrick J Creaven; James Schwartz; Michael G Brattain; Alan Hutson; Renee French; Candace S Johnson
A phase I pharmacokinetic and pharmacodynamic study of intravenous calcitriol in combination with oral gefitinib in patients with advanced solid tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(4):1216-23.
2007: Josephia R Muindi; Yibing Peng; John W Wilson; Candace S Johnson; Robert A Branch; Donald L Trump
Monocyte fructose 1,6-bisphosphatase and cytidine deaminase enzyme activities: potential pharmacodynamic measures of calcitriol effects in cancer patients.
Cancer chemotherapy and pharmacology 2007;59(1):97-104.
2006: James E Montie; Neil A Abrahams; Robert R Bahnson; Mario A Eisenberger; Rizk El-Galley; Harry W Herr; Gary R Hudes; Timothy M Kuzel; Paul H Lange; Anthony Patterson; Alan Pollack; Jerome P Richie; Wade J Sexton; William U Shipley; Eric J Small; Donald L Trump; Phillip J Walther; Timothy G Wilson
Bladder cancer. Clinical guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2006;4(10):984-1014.
2006: Ivy Chung; Michael K Wong; Geraldine Flynn; Wei-Dong Yu; Candace S Johnson; Donald L Trump
Differential antiproliferative effects of calcitriol on tumor-derived and matrigel-derived endothelial cells.
Cancer research 2006;66(17):8565-73.
2006: Yingyu Ma; Wei-Dong Yu; Rui-Xian Kong; Donald L Trump; Candace S Johnson
Role of nongenomic activation of phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase 1/2 pathways in 1,25D3-mediated apoptosis in squamous cell carcinoma cells.
Cancer research 2006;66(16):8131-8.
2006: Donald L Trump; Josephia R Muindi; Marwan G Fakih; Wei-Dong Yu; Candace S Johnson
Vitamin D compounds: clinical development as cancer therapy and prevention agents.
Anticancer research 2006;26(4A):2551-6.
2006: Candace S Johnson; Josephia R Muindi; Pamela A Hershberger; Donald L Trump
The antitumor efficacy of calcitriol: preclinical studies.
Anticancer research 2006;26(4A):2543-9.
2006: Soo Ok Lee; Jae Yeon Chun; Nagalakshmi Nadiminty; Donald L Trump; Clement Ip; Yan Dong; Allen C Gao
Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA).
The Prostate 2006;66(10):1070-5.
2006: Donald L Trump; Douglas M Potter; Josephia R Muindi; Adam Brufsky; Candace S Johnson
Phase II trial of high-dose, intermittent calcitriol (1,25 dihydroxyvitamin D3) and dexamethasone in androgen-independent prostate cancer.
Cancer 2006;106(10):2136-42.
2006: Nagalakshmi Nadiminty; Wei Lou; Soo Ok Lee; Xin Lin; Donald L Trump; Allen C Gao
Stat3 activation of NF-{kappa}B p100 processing involves CBP/p300-mediated acetylation.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(19):7264-9.
2006: Ramesh K Ramanathan; Marwan G Fakih; Sridhar Mani; Melvin Deutsch; Raymond P Perez; Mark A Ritter; Julie L Eiseman; S Percy Ivy; Donald L Trump; Chandra P Belani; Robert A Parise; Douglas M Potter; Merrill J Egorin
Phase I and pharmacokinetic study of the novel redox-active agent, motexafin gadolinium, with concurrent radiation therapy in patients with locally advanced pancreatic or biliary cancers.
Cancer chemotherapy and pharmacology 2006;57(4):465-74.
2006: Adebusola A Alagbala; Candace S Johnson; Donald L Trump; Gary H Posner; Barbara A Foster
Antitumor effects of two less-calcemic vitamin D analogs (Paricalcitol and QW-1624F2-2) in squamous cell carcinoma cells.
Oncology 2006;70(6):483-92.
2006: Geraldine Flynn; Ivy Chung; Wei-Dong Yu; Michelle Romano; Ruth A Modzelewski; Candace S Johnson; Donald L Trump
Calcitriol (1,25-dihydroxycholecalciferol) selectively inhibits proliferation of freshly isolated tumor-derived endothelial cells and induces apoptosis.
Oncology 2006;70(6):447-57.
2006: Joseph Zmuda; Francesmary Modugno; Joel L Weissfeld; Jane A Cauley; Donald L Trump; Susan P Moffett; Robert E Ferrell
Peroxisome proliferator-activated receptor-gamma polymorphism, body mass and prostate cancer risk: evidence for gene-environment interaction.
Oncology 2006;70(3):185-9.
2005: Susan L Greenspan; Penelope Coates; Susan M Sereika; Joel B Nelson; Donald L Trump; Neil M Resnick
Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer.
The Journal of clinical endocrinology and metabolism 2005;90(12):6410-7.
2005: Josephia R Muindi; Douglas M Potter; Yibing Peng; Candace S Johnson; Donald L Trump
Pharmacokinetics of liquid calcitriol formulation in advanced solid tumor patients: comparison with caplet formulation.
Cancer chemotherapy and pharmacology 2005;56(5):492-6.
2005: Dongfeng Tan; Xiuxian Wu; Min Hou; Soo Ok Lee; Wei Lou; Jianmin Wang; Bagirathan Janarthan; Sujatha Nallapareddy; Donald L Trump; Allen C Gao
Interleukin-6 polymorphism is associated with more aggressive prostate cancer.
The Journal of urology 2005;174(2):753-6.
2005: Shivendra V Singh; Sanjay Srivastava; Sunga Choi; Karen L Lew; Jedrzej Antosiewicz; Dong Xiao; Yan Zeng; simon simon watkins; Candace S Johnson; Donald L Trump; Yong J Lee; Hui Xiao; Anna Herman-Antosiewicz
Sulforaphane-induced cell death in human prostate cancer cells is initiated by reactive oxygen species.
The Journal of biological chemistry 2005;280(20):19911-24.
2005: Ramesh K Ramanathan; Donald L Trump; Julie L Eiseman; Chandra P Belani; Sanjiv S Agarwala; Eleanor G Zuhowski; Jing Lan; Douglas M Potter; S Percy Ivy; Sakkaraiappan Ramalingam; Adam Brufsky; Michael K K Wong; Susan Tutchko; Merrill J Egorin
Phase I pharmacokinetic-pharmacodynamic study of 17-(allylamino)-17-demethoxygeldanamycin (17AAG, NSC 330507), a novel inhibitor of heat shock protein 90, in patients with refractory advanced cancers.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(9):3385-91.
2005: Xueyu Chen; Robert R Bies; Ramesh K Ramanathan; Eleanor G Zuhowski; Donald L Trump; Merrill J Egorin
Population pharmacokinetic analysis of 17-(allylamino)-17-demethoxygeldanamycin (17AAG) in adult patients with advanced malignancies.
Cancer chemotherapy and pharmacology 2005;55(3):237-43.
2004: Laura L Jung; Ramesh K Ramanathan; Merrill J Egorin; Ruzhi Jin; Chandra P Belani; Douglas M Potter; Sandra Strychor; Donald L Trump; Christine M Walko; Marwan G Fakih; William C Zamboni
Pharmacokinetic studies of 9-nitrocamptothecin on intermittent and continuous schedules of administration in patients with solid tumors.
Cancer chemotherapy and pharmacology 2004;54(6):487-96.
2004: Soo Ok Lee; Wei Lou; Khusroo M Qureshi; Farideh Mehraein-Ghomi; Donald L Trump; Allen C Gao
RNA interference targeting Stat3 inhibits growth and induces apoptosis of human prostate cancer cells.
The Prostate 2004;60(4):303-9.
2004: William C Zamboni; Laura L Jung; Merrill J Egorin; Douglas M Potter; David M Friedland; Chandra P Belani; Sanjiv S Agarwala; Michael M W Wong; Marwan G Fakih; Donald L Trump; Ruzhi Jin; Sandra Strychor; Michael Vozniak; Monica Troetschel; Ramesh K Ramanathan
Phase I and pharmacologic study of intermittently administered 9-nitrocamptothecin in patients with advanced solid tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(15):5058-64.
2004: Soo Ok Lee; Wei Lou; Candace S Johnson; Donald L Trump; Allen C Gao
Interleukin-6 protects LNCaP cells from apoptosis induced by androgen deprivation through the Stat3 pathway.
The Prostate 2004;60(3):178-86.
2004: Dong Xiao; Sunga Choi; Daniel E Johnson; Victor Vogel; Candace S Johnson; Donald L Trump; Yong J Lee; Shivendra V Singh
Diallyl trisulfide-induced apoptosis in human prostate cancer cells involves c-Jun N-terminal kinase and extracellular-signal regulated kinase-mediated phosphorylation of Bcl-2.
Oncogene 2004;23(33):5594-606.
2004: Donald L Trump; Pamela A Hershberger; Ronald J Bernardi; Sharmilla Ahmed; Josephia R Muindi; Marwan G Fakih; Wei-Dong Yu; Candace S Johnson
Anti-tumor activity of calcitriol: pre-clinical and clinical studies.
The Journal of steroid biochemistry and molecular biology 2004;89-90(1-5):519-26.
2004: Dong Xiao; Candace S Johnson; Donald L Trump; Shivendra V Singh
Proteasome-mediated degradation of cell division cycle 25C and cyclin-dependent kinase 1 in phenethyl isothiocyanate-induced G2-M-phase cell cycle arrest in PC-3 human prostate cancer cells.
Molecular cancer therapeutics 2004;3(5):567-75.
2004: Josephia R Muindi; Ruth A Modzelewski; Yibing Peng; Donald L Trump; Candace S Johnson
Pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 in normal mice after systemic exposure to effective and safe antitumor doses.
Oncology 2004;66(1):62-6.
2004: Linda J Hoffman; Clareann H Bunker; Philip E Pellett; Donald L Trump; Alan L Patrick; Sheila C Dollard; Hillary A Keenan; Frank J Jenkins
Elevated seroprevalence of human herpesvirus 8 among men with prostate cancer.
The Journal of infectious diseases 2004;189(1):15-20.
2003: Sanjay Srivastava; Dong Xiao; Karen L Lew; Pamela A Hershberger; Demetrius M Kokkinakis; Candace S Johnson; Donald L Trump; Shivendra V Singh
Allyl isothiocyanate, a constituent of cruciferous vegetables, inhibits growth of PC-3 human prostate cancer xenografts in vivo.
Carcinogenesis 2003;24(10):1665-70.
2003: Josephia R Muindi; John W Wilson; Ying Peng; Mary Jo Capozolli; Candace S Johnson; Donald L Trump
A limited sampling method for the estimation of serum calcitriol area under the curve in cancer patients.
Journal of clinical pharmacology 2003;43(8):894-900.
2003: Dong Xiao; Sanjay Srivastava; Karen L Lew; Yan Zeng; Pamela A Hershberger; Candace S Johnson; Donald L Trump; Shivendra V Singh
Allyl isothiocyanate, a constituent of cruciferous vegetables, inhibits proliferation of human prostate cancer cells by causing G2/M arrest and inducing apoptosis.
Carcinogenesis 2003;24(5):891-7.
2003: Avni Patel; Penelope S Coates; Joel B Nelson; Donald L Trump; Neil M Resnick; Susan L Greenspan
Does bone mineral density and knowledge influence health-related behaviors of elderly men at risk for osteoporosis?
Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2003;6(4):323-30.
2002: Josephia R Muindi; Yibing Peng; Douglas M Potter; Pamela A Hershberger; Jil S Tauch; Mary Jo Capozzoli; Merrill J Egorin; Candace S Johnson; Donald L Trump
Pharmacokinetics of high-dose oral calcitriol: results from a phase 1 trial of calcitriol and paclitaxel.
Clinical pharmacology and therapeutics 2002;72(6):648-59.
2002: Theodore F Logan; Fayega Jadali; Merrill J Egorin; Mark Mintun; Donald Sashin; William Gooding; Yong Choi; Harry Bishop; Donald L Trump; Diane Gardner; John Kirkwood; Daniel Vlock; Candace Johnson
Decreased tumor blood flow as measured by positron emission tomography in cancer patients treated with interleukin-1 and carboplatin on a phase I trial.
Cancer chemotherapy and pharmacology 2002;50(6):433-44.
2002: Ramesh K Ramanathan; Douglas M Potter; Chandra P Belani; Samuel A Jacobs; Stefan Gravenstein; Felix Lim; Hyoung Kim; Steven Savona; Terry Evans; Dianne Buchbarker; Mary B Simon; Jane K Depee; Donald L Trump
Randomized trial of influenza vaccine with granulocyte-macrophage colony-stimulating factor or placebo in cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(21):4313-8.
2002: Marwan G Fakih; Candace S Johnson; Donald L Trump
Glucocorticoids and treatment of prostate cancer: a preclinical and clinical review.
Urology 2002;60(4):553-61.
2002: Candace S Johnson; Pamela A Hershberger; Ronald J Bernardi; Terence F Mcguire; Donald L Trump
Vitamin D receptor: a potential target for intervention.
Urology 2002;60(3 Suppl 1):123-30; discussion 130-1.
2002: Khalid Matin; Merrill J Egorin; Michael F Ballesteros; David C Smith; Barry C Lembersky; Roger S Day; Candace S Johnson; Donald L Trump
Phase I and pharmacokinetic study of vinblastine and high-dose megestrol acetate.
Cancer chemotherapy and pharmacology 2002;50(3):179-85.
2002: Pamela A Hershberger; Terence F Mcguire; Wei-Dong Yu; Eleanor G Zuhowski; Jan H M Schellens; Merrill J Egorin; Donald L Trump; Candace S Johnson
Cisplatin potentiates 1,25-dihydroxyvitamin D3-induced apoptosis in association with increased mitogen-activated protein kinase kinase kinase 1 (MEKK-1) expression.
Molecular cancer therapeutics 2002;1(10):821-9.
2002: Clareann H Bunker; Alan L Patrick; Badrinath R Konety; Rajiv Dhir; Adam Brufsky; Carlos Vivas; Michael Becich; Donald L Trump; Lewis H Kuller
High prevalence of screening-detected prostate cancer among Afro-Caribbeans: the Tobago Prostate Cancer Survey.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2002;11(8):726-9.
2002: Sharmila Ahmed; Candace S Johnson; Robert M Rueger; Donald L Trump
Calcitriol (1,25-dihydroxycholecalciferol) potentiates activity of mitoxantrone/dexamethasone in an androgen independent prostate cancer model.
The Journal of urology 2002;168(2):756-61.
2002: Ronald J Bernardi; Candace S Johnson; Ruth A Modzelewski; Donald L Trump
Antiproliferative effects of 1alpha,25-dihydroxyvitamin D(3) and vitamin D analogs on tumor-derived endothelial cells.
Endocrinology 2002;143(7):2508-14.
2002: Sharmila Ahmed; Donald L Trump
The case for early androgen deprivation: the data should not be ignored.
Urologic oncology 2002;7(2):77-80.
2001: Ronald J Bernardi; Donald L Trump; Wei-Dong Yu; Terence F Mcguire; Pamela A Hershberger; Candace S Johnson
Combination of 1alpha,25-dihydroxyvitamin D(3) with dexamethasone enhances cell cycle arrest and apoptosis: role of nuclear receptor cross-talk and Erk/Akt signaling.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(12):4164-73.
2001: Francesmary Modugno; J L Weissfeld; Donald L Trump; Joseph Zmuda; Patrick R Shea; Jane A Cauley; Robert E Ferrell
Allelic variants of aromatase and the androgen and estrogen receptors: toward a multigenic model of prostate cancer risk.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(10):3092-6.
2001: Stephen J Winters; Adam Brufsky; J Weissfeld; Donald L Trump; M A Dyky; Venus Hadeed
Testosterone, sex hormone-binding globulin, and body composition in young adult African American and Caucasian men.
Metabolism: clinical and experimental 2001;50(10):1242-7.
2001: Terence F Mcguire; Donald L Trump; Candace S Johnson
Vitamin D(3)-induced apoptosis of murine squamous cell carcinoma cells. Selective induction of caspase-dependent MEK cleavage and up-regulation of MEKK-1.
The Journal of biological chemistry 2001;276(28):26365-73.
2001: Pamela A Hershberger; Wei-Dong Yu; Ruth A Modzelewski; Robert M Rueger; Candace S Johnson; Donald L Trump
Calcitriol (1,25-dihydroxycholecalciferol) enhances paclitaxel antitumor activity in vitro and in vivo and accelerates paclitaxel-induced apoptosis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(4):1043-51.
2001: Donald L Trump; J A Waldstreicher; G Kolvenbag; P S Wissel; B L Neubauer
Androgen antagonists: Potential role in prostate cancer prevention.
Urology 2001;57(4 Suppl 1):64-7.
2001: Badrinath R Konety; John Lavelle; G Pirtskalaishvili; Rajiv Dhir; Susan A Meyers; TS Nguyen; Pamela A Hershberger; Michael R Shurin; Candace S Johnson; Donald L Trump; Mark L Zeidel; Robert H Getzenberg
Effects of vitamin D (calcitriol) on transitional cell carcinoma of the bladder in vitro and in vivo.
The Journal of urology 2001;165(1):253-8.
2000: Qing Zeng; David C Smith; Todd J Suscovich; William Gooding; Donald L Trump; Jennifer Rubin Grandis
Determination of intermediate biomarker expression levels by quantitative reverse transcription-polymerase chain reaction in oral mucosa of cancer patients treated with liarozole.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(6):2245-51.
1999: David C Smith; Candace S Johnson; C C Freeman; Josephia R Muindi; John W Wilson; Donald L Trump
A Phase I trial of calcitriol (1,25-dihydroxycholecalciferol) in patients with advanced malignancy.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(6):1339-45.
1999: Pamela A Hershberger; Ruth A Modzelewski; Z R Shurin; Robert M Rueger; Donald L Trump; Candace S Johnson
1,25-Dihydroxycholecalciferol (1,25-D3) inhibits the growth of squamous cell carcinoma and down-modulates p21(Waf1/Cip1) in vitro and in vivo.
Cancer research 1999;59(11):2644-9.
1999: P V Woolley; F S Freiha; David C Smith; Lois Carlson; J Hofacker; N Quinn; William M Grove; Donald L Trump
A phase II trial of CI-958 in patients with hormone-refractory prostate cancer.
Cancer chemotherapy and pharmacology 1999;44(6):511-7.
1998: Venus Hadeed; Donald L Trump; C Mies
Electronic cancer Munchausen syndrome.
Annals of internal medicine 1998;129(1):73.
1998: Wei-Dong Yu; MC McElwain; Ruth A Modzelewski; DM Russell; David C Smith; Donald L Trump; Candace S Johnson
Enhancement of 1,25-dihydroxyvitamin D3-mediated antitumor activity with dexamethasone.
Journal of the National Cancer Institute 1998;90(2):134-41.
1998: Adedayo Adedoyin; D D Stiff; David C Smith; Marjorie Romkes; R C Bahnson; R Day; J Hofacker; Robert A Branch; Donald L Trump
All-trans-retinoic acid modulation of drug-metabolizing enzyme activities: investigation with selective metabolic drug probes.
Cancer chemotherapy and pharmacology 1998;41(2):133-9.
1997: Robert H Getzenberg; BW Light; P E Lapco; Badrinath R Konety; AK Nangia; J S Acierno; Rajiv Dhir; Z Shurin; Roger S Day; Donald L Trump; Candace S Johnson
Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system.
Urology 1997;50(6):999-1006.
1997: BW Light; Wei-Dong Yu; MC McElwain; DM Russell; Donald L Trump; Candace S Johnson
Potentiation of cisplatin antitumor activity using a vitamin D analogue in a murine squamous cell carcinoma model system.
Cancer research 1997;57(17):3759-64.
1997: Wei-Dong Yu; M J Chang; Donald L Trump; Candace S Johnson
Interleukin-1alpha synergistic in vivo enhancement of cyclophosphamide- and carboplatin-mediated antitumor activity.
Cancer immunology, immunotherapy : CII 1997;44(6):316-22.
1997: Donald L Trump; David C Smith; D Stiff; Adedayo Adedoyin; R Day; Robert R Bahnson; J Hofacker; Robert A Branch
A phase II trial of all-trans-retinoic acid in hormone-refractory prostate cancer: a clinical trial with detailed pharmacokinetic analysis.
Cancer chemotherapy and pharmacology 1997;39(4):349-56.
1996: David C Smith; S L Gerson; L Liu; S Donnelly; R Day; Donald L Trump; John M Kirkwood
Carmustine and streptozocin in refractory melanoma: an attempt at modulation of O-alkylguanine-DNA-alkyltransferase.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(7):1129-34.
1995: J L Osborn; Gary G Schwartz; D C Smith; Robert R Bahnson; R Day; Donald L Trump
Phase II trial of oral 1,25-dihydroxyvitamin D (calcitriol) in hormone refractory prostate cancer.
Urologic oncology 1995;1(5):195-8.